Pci For Ischemic Left Ventricular Dysfunction Nejm
The Heart рџ ґ Effect Of Pci On Health Status In Ischemic In the revascularization for ischemic ventricular dysfunction (revived) trial, we hypothesized that revascularization with pci in addition to optimal medical therapy for heart failure, as. Pci for ischemic left ventricular dysfunction in a randomized trial involving patients with a low lvef and viable myocardium who received optimal medical therapy, pci did not lead to a lower incidence of death or hospitalization for heart failure.
Mohammad Vaziri Na Linkedin Pci For Ischemic Left Ventricular Mesh terms humans myocardial ischemia* complications myocardial ischemia* therapy percutaneous coronary intervention* ventricular dysfunction, left* etiology. The left ventricular ejection fraction was similar in the two groups at 6 months (mean difference, −1.6 percentage points; 95% ci, −3.7 to 0.5) and at 12 months (mean difference, 0.9 percentage points; 95% ci, −1.7 to 3.4). Finally, a step by step guide for planning and performing pci in this population is provided. attention is given to shared decision making, nontechnical factors, and considerations for achieving complete revascularization, with a specific focus on upcoming trials of mechanical circulatory support. Among patients with severe ischemic left ventricular systolic dysfunction who received optimal medical therapy, revascularization by pci did not result in a lower incidence of death from any cause or hospitalization for heart failure.
The Revived Trial Pci In Patients With Severe Ischemic Left Finally, a step by step guide for planning and performing pci in this population is provided. attention is given to shared decision making, nontechnical factors, and considerations for achieving complete revascularization, with a specific focus on upcoming trials of mechanical circulatory support. Among patients with severe ischemic left ventricular systolic dysfunction who received optimal medical therapy, revascularization by pci did not result in a lower incidence of death from any cause or hospitalization for heart failure. Among patients with severe ischemic left ventricular systolic dysfunction who re ceived optimal medical therapy, revascularization by pci did not result in a lower incidence of death from any cause or hospitalization for heart failure. Whether percutaneous coronary intervention, when added to optimal medical therapy, can improve outcomes in patients with severe ischemic left ventricular systolic dysfunction is unknown. Study findings indicate that routine pci as a treatment strategy for ischemic left ventricular systolic dysfunction is not cost effective, which has implications for health care resource allocation. Major secondary outcomes were left ventricular ejection fraction at 6 and 12 months and quality of life scores.a total of 700 patients underwent randomization 347 were assigned to the pci group and 353 to the optimal medical therapy group.
Case 6 Pci In A Patient With Severe Left Ventricular Dysfunction Among patients with severe ischemic left ventricular systolic dysfunction who re ceived optimal medical therapy, revascularization by pci did not result in a lower incidence of death from any cause or hospitalization for heart failure. Whether percutaneous coronary intervention, when added to optimal medical therapy, can improve outcomes in patients with severe ischemic left ventricular systolic dysfunction is unknown. Study findings indicate that routine pci as a treatment strategy for ischemic left ventricular systolic dysfunction is not cost effective, which has implications for health care resource allocation. Major secondary outcomes were left ventricular ejection fraction at 6 and 12 months and quality of life scores.a total of 700 patients underwent randomization 347 were assigned to the pci group and 353 to the optimal medical therapy group.
Comments are closed.